Crossmark

Cardiac and renal AL amyloidosis controlled by autologous stem cell transplantation for 17 years accompanying late onset atrial fibrillation and complete atrioventricular block

Crossref DOI link: https://doi.org/10.1007/s13730-023-00777-8

Published Online: 2023-02-16

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Iijima, Takashi http://orcid.org/0000-0002-9266-9080
Sawa, Naoki

Oba, Yuki

Ikuma, Daisuke

Mizuno, Hiroki

Yamanouchi, Masayuki

Suwabe, Tatsuya

Wake, Atsushi

Kono, Kei

Ubara, Yoshifumi

Ohashi, Kenichi
License Information

Text and Data Mining valid from 2023-02-16

Version of Record valid from 2023-02-16
More Information

Article History

Received: 20 August 2022

Accepted: 6 February 2023

First Online: 16 February 2023

Declarations

:

: The authors have declared that no conflict of interest exists.

: The patient gave us his informed consent on HDM-ASCT. The study conforms to the Declaration of Helsinki.

Document is current

Any future updates will be listed below